CervoMed Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-27.0M | $-16.3M | $-2.2M | $-5.8M | $-24.1M | $-14.2M | $-11.8M | $-18.4M |
| Depreciation & Amortization | — | — | — | $0 | $93.4K | $103.2K | — | — |
| Depreciation | — | — | — | $0 | $93.4K | $103.2K | $97.9K | $110.4K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.4M | $1.4M | $407.6K | $333.8K | $897.3K | $736.1K | $515.8K | $1.2M |
| Net Cash from Operating Activities | $-23.4M | $-16.5M | $-7.4M | $-2.6M | $-14.5M | $-13.6M | $-9.9M | $-10.8M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $18.1M | $-28.7M | $0 | $-12.2M | $4.0K | $0 | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $4.6M | $46.4M | $11.1M | $0 | $33.3M | $17.9M | $16.0M | $9.9M |
| Net Change in Cash | $-764.0K | $1.2M | $3.7M | $-2.6M | $18.8M | $4.3M | $6.2M | $-905.3K |
| Free Cash Flow | — | — | — | — | — | — | — | — |